Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1968 1
1969 2
1970 1
1971 2
1972 3
1975 2
1976 3
1977 2
1978 9
1979 8
1980 11
1981 7
1982 16
1983 28
1984 35
1985 34
1986 37
1987 30
1988 53
1989 60
1990 52
1991 53
1992 72
1993 78
1994 100
1995 111
1996 107
1997 72
1998 95
1999 92
2000 73
2001 78
2002 71
2003 81
2004 73
2005 69
2006 70
2007 63
2008 61
2009 34
2010 39
2011 56
2012 57
2013 59
2014 40
2015 42
2016 37
2017 35
2018 32
2019 33
2020 33
2021 27
2022 35
2023 30
2024 29
2025 25
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,317 results

Results by year

Filters applied: . Clear all
Page 1
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C. Ajani JA, et al. JAMA. 2008 Apr 23;299(16):1914-21. doi: 10.1001/jama.299.16.1914. JAMA. 2008. PMID: 18430910 Clinical Trial.
The 5-year overall survival rate was 75% (95% CI, 67%-81%) in the mitomycin-based group and 70% (95% CI, 63%-76%) in the cisplatin-based group (P = .10). ...The cumulative rate of colostomy was significantly better for mitomycin-based than cisplatin-based treatment …
The 5-year overall survival rate was 75% (95% CI, 67%-81%) in the mitomycin-based group and 70% (95% CI, 63%-76%) in the cisplatin-ba …
A comparative clinical trial of mitomycin C and cyclosporin A in trabeculectomy.
Turaçli E, Gündüz K, Aktan G, Tamer C. Turaçli E, et al. Eur J Ophthalmol. 1996 Oct-Dec;6(4):398-401. doi: 10.1177/112067219600600410. Eur J Ophthalmol. 1996. PMID: 8997582 Clinical Trial.

According to these criteria, IOP was under control in 90% of the mitomycin C treated eyes, 85.7% of cyclosporin A treated eyes and 71.4% of the control eyes. Postoperatively there was a significant decrease in IOP (p < 0.01) and in the number of medications need to cont

…
According to these criteria, IOP was under control in 90% of the mitomycin C treated eyes, 85.7% of cyclosporin A treated eyes and 71 …
Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer.
Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, Rockwell S, Sartorelli AC, Fischer JJ. Weissberg JB, et al. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):3-9. doi: 10.1016/0360-3016(89)90362-3. Int J Radiat Oncol Biol Phys. 1989. PMID: 2501243 Clinical Trial.
Actuarial disease-free survival at 5 years was 49% in the radiation therapy group and 75% in the radiation therapy plus mitomycin C group, p less than 0.07. Local recurrence-free survival was 66% in the radiation therapy group and 87% in the radiation therapy plus mitom …
Actuarial disease-free survival at 5 years was 49% in the radiation therapy group and 75% in the radiation therapy plus mitomycin C g …
Chemotherapy of cervical cancer.
Guthrie D. Guthrie D. Clin Obstet Gynaecol. 1985 Mar;12(1):229-46. Clin Obstet Gynaecol. 1985. PMID: 3922658 Review.
Intravesical chemotherapy.
Prout GR Jr. Prout GR Jr. Prog Clin Biol Res. 1984;162B:125-50. Prog Clin Biol Res. 1984. PMID: 6438639 Review. No abstract available.
To Compare Efficacy Between Cryotherapy And Mitomycin Microneedling For The Treatment Of Plantar Warts.
Khan FA, Hussain M, Khan BM, Afsar S, Shafique M, Haq SU, Akbar N, Siddique A. Khan FA, et al. J Ayub Med Coll Abbottabad. 2023 Feb-Mar;35(1):133-136. doi: 10.55519/JAMC-01-10932. J Ayub Med Coll Abbottabad. 2023. PMID: 36849393 Free article. Clinical Trial.
Complete remission was observed after two to three sessions of mitomycin microneedling while average of 4 sessions of cryotherapy were required for complete remission. In general, microneedling with mitomycin had better tolerance, pain being the commonest adverse ef …
Complete remission was observed after two to three sessions of mitomycin microneedling while average of 4 sessions of cryotherapy wer …
The role of anthracyclines in the treatment of gastric cancer.
Wadler S, Green M, Muggia F. Wadler S, et al. Cancer Treat Rev. 1985 Jun;12(2):105-32. doi: 10.1016/0305-7372(85)90003-9. Cancer Treat Rev. 1985. PMID: 3902215 Review.
Prior to 1974 gastric cancer was considered refractory to chemotherapy. Single agent 5-Fluorouracil, mitomycin, and the nitrosoureas produced modest response rates with no augmentation of survival as compared to historical controls. ...The addition of doxorubicin, which ha …
Prior to 1974 gastric cancer was considered refractory to chemotherapy. Single agent 5-Fluorouracil, mitomycin, and the nitrosoureas …
Mitomycin therapy in gastric cancer.
Schnall S, Macdonald JS. Schnall S, et al. Oncology. 1993 Apr;50 Suppl 1:70-7. doi: 10.1159/000227249. Oncology. 1993. PMID: 8483560 Review.
Mitomycin has also demonstrated efficacy when given in combination with doxorubicin and in the three-drug regimen FAM (5-fluorouracil/doxorubicin/mitomycin). ...Mitomycin will undoubtedly play a role in the development of new approaches to the treatment of ga …
Mitomycin has also demonstrated efficacy when given in combination with doxorubicin and in the three-drug regimen FAM (5-fluorouracil …
A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.
Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. Chen PP, et al. Am J Ophthalmol. 1995 Aug;120(2):151-60. doi: 10.1016/s0002-9394(14)72602-9. Am J Ophthalmol. 1995. PMID: 7639298 Clinical Trial.
PURPOSE: To determine the rate of recurrence and complications after bare sclera excision of primary pterygia followed by low-dose mitomycin C (0.2 mg/ml twice daily for five days), placebo (balanced saline solution), or conjunctival autograft. ...RESULTS: The recurrence r …
PURPOSE: To determine the rate of recurrence and complications after bare sclera excision of primary pterygia followed by low-dose mitomy …
Trabeculectomy with mitomycin C: an electron microscopic and clinical study.
Turáçli ME, Gündüz K, Aktan G, Sencer H. Turáçli ME, et al. Int Ophthalmol. 1995-1996;19(6):337-46. doi: 10.1007/BF00130852. Int Ophthalmol. 1995. PMID: 8970867 Clinical Trial.

The study population consisted of 26 patients undergoing mitomycin C-aided trabeculectomy and another 26 patients subjected to trabeculectomy without mitomycin C serving as controls. ...The decrease in IOP was more marked (P < 0.01) and the number of additional m

…
The study population consisted of 26 patients undergoing mitomycin C-aided trabeculectomy and another 26 patients subjected to trabec …
2,317 results